S&P 500   4,064.73 (-0.38%)
DOW   34,270.73 (-0.92%)
QQQ   292.19 (-0.40%)
AAPL   147.15 (-0.59%)
MSFT   252.34 (-1.10%)
META   119.19 (+0.92%)
GOOGL   100.66 (-0.33%)
AMZN   95.92 (-0.64%)
TSLA   193.85 (-0.44%)
NVDA   169.60 (+0.22%)
NIO   12.28 (-3.91%)
BABA   85.87 (-1.93%)
AMD   76.54 (-1.40%)
T   19.17 (-0.57%)
MU   55.46 (-3.80%)
CGC   3.67 (+1.38%)
F   14.14 (+1.73%)
GE   85.52 (-0.52%)
DIS   97.87 (+0.00%)
AMC   8.27 (+14.38%)
PYPL   78.35 (-0.08%)
PFE   50.49 (+0.72%)
NFLX   315.12 (+3.14%)
S&P 500   4,064.73 (-0.38%)
DOW   34,270.73 (-0.92%)
QQQ   292.19 (-0.40%)
AAPL   147.15 (-0.59%)
MSFT   252.34 (-1.10%)
META   119.19 (+0.92%)
GOOGL   100.66 (-0.33%)
AMZN   95.92 (-0.64%)
TSLA   193.85 (-0.44%)
NVDA   169.60 (+0.22%)
NIO   12.28 (-3.91%)
BABA   85.87 (-1.93%)
AMD   76.54 (-1.40%)
T   19.17 (-0.57%)
MU   55.46 (-3.80%)
CGC   3.67 (+1.38%)
F   14.14 (+1.73%)
GE   85.52 (-0.52%)
DIS   97.87 (+0.00%)
AMC   8.27 (+14.38%)
PYPL   78.35 (-0.08%)
PFE   50.49 (+0.72%)
NFLX   315.12 (+3.14%)
S&P 500   4,064.73 (-0.38%)
DOW   34,270.73 (-0.92%)
QQQ   292.19 (-0.40%)
AAPL   147.15 (-0.59%)
MSFT   252.34 (-1.10%)
META   119.19 (+0.92%)
GOOGL   100.66 (-0.33%)
AMZN   95.92 (-0.64%)
TSLA   193.85 (-0.44%)
NVDA   169.60 (+0.22%)
NIO   12.28 (-3.91%)
BABA   85.87 (-1.93%)
AMD   76.54 (-1.40%)
T   19.17 (-0.57%)
MU   55.46 (-3.80%)
CGC   3.67 (+1.38%)
F   14.14 (+1.73%)
GE   85.52 (-0.52%)
DIS   97.87 (+0.00%)
AMC   8.27 (+14.38%)
PYPL   78.35 (-0.08%)
PFE   50.49 (+0.72%)
NFLX   315.12 (+3.14%)
S&P 500   4,064.73 (-0.38%)
DOW   34,270.73 (-0.92%)
QQQ   292.19 (-0.40%)
AAPL   147.15 (-0.59%)
MSFT   252.34 (-1.10%)
META   119.19 (+0.92%)
GOOGL   100.66 (-0.33%)
AMZN   95.92 (-0.64%)
TSLA   193.85 (-0.44%)
NVDA   169.60 (+0.22%)
NIO   12.28 (-3.91%)
BABA   85.87 (-1.93%)
AMD   76.54 (-1.40%)
T   19.17 (-0.57%)
MU   55.46 (-3.80%)
CGC   3.67 (+1.38%)
F   14.14 (+1.73%)
GE   85.52 (-0.52%)
DIS   97.87 (+0.00%)
AMC   8.27 (+14.38%)
PYPL   78.35 (-0.08%)
PFE   50.49 (+0.72%)
NFLX   315.12 (+3.14%)
NYSE:WST

West Pharmaceutical Services - WST Stock Forecast, Price & News

$239.29
+4.63 (+1.97%)
(As of 12/1/2022 12:01 PM ET)
Add
Compare
Today's Range
$232.77
$239.29
50-Day Range
$209.34
$261.61
52-Week Range
$206.19
$475.00
Volume
11,240 shs
Average Volume
798,245 shs
Market Capitalization
$17.71 billion
P/E Ratio
28.86
Dividend Yield
0.34%
Price Target
$283.33

West Pharmaceutical Services MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
21.1% Upside
$283.33 Price Target
Short Interest
Healthy
1.35% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.53
Upright™ Environmental Score
News Sentiment
0.20mentions of West Pharmaceutical Services in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-8.56%
From $8.18 to $7.48 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Medical Sector

511th out of 1,047 stocks

Fabricated Rubber Products, Not Elsewhere Classified Industry

2nd out of 2 stocks

WST stock logo

About West Pharmaceutical Services (NYSE:WST) Stock

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Stock News Headlines

West to Host Third-Quarter 2022 Conference Call
West Pharmaceutical Services, Inc. (WST)
WST West Pharmaceutical Services, Inc.
West Pharmaceutical Services (NYSE: WST)
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Company Calendar

Last Earnings
10/27/2022
Ex-Dividend for 11/16 Dividend
11/08/2022
Dividend Payable
11/16/2022
Today
12/01/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/16/2023

Industry, Sector and Symbol

Industry
Fabricated rubber products, not elsewhere classified
Sub-Industry
Health Care Supplies
Sector
Medical
CUSIP
95530610
Employees
10,065
Year Founded
1923

Price Target and Rating

Average Stock Price Forecast
$283.33
High Stock Price Forecast
$350.00
Low Stock Price Forecast
$250.00
Forecasted Upside/Downside
+18.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$661.80 million
Pretax Margin
25.20%

Debt

Sales & Book Value

Annual Sales
$2.83 billion
Cash Flow
$11.21 per share
Book Value
$33.37 per share

Miscellaneous

Free Float
73,589,000
Market Cap
$17.71 billion
Optionable
Optionable
Beta
1.15

Social Links


Key Executives

  • Mr. Eric M. Green (Age 52)
    Chair, Pres & CEO
    Comp: $3.42M
  • Mr. Bernard J. Birkett (Age 53)
    Sr. VP and Chief Financial & Operations Officer
    Comp: $1.5M
  • Mr. Silji AbrahamMr. Silji Abraham (Age 50)
    Sr. VP & Chief Technology Officer
    Comp: $1.11M
  • Ms. Kimberly Banks MacKay (Age 56)
    Sr. VP, Gen. Counsel & Company Sec.
    Comp: $946.43k
  • Mr. Chad R. Winters (Age 43)
    VP, Chief Accounting Officer & Corp. Controller
  • Dr. Quintin J. Lai C.F.A. (Age 55)
    Ph.D., VP of Strategy & Investor Relations
  • Michele Polinsky
    VP of Global Communications
  • Mr. Robert Segura
    VP of Corp. Devel.
  • Ms. Annette F. FavoriteMs. Annette F. Favorite (Age 57)
    Chief HR Officer & Sr. VP
  • Mr. Richard D. Luzzi (Age 70)
    Sr. VP of HR













WST Stock - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" WST shares.
View WST analyst ratings
or view top-rated stocks.

What is West Pharmaceutical Services' stock price forecast for 2023?

4 brokerages have issued 12 month price objectives for West Pharmaceutical Services' stock. Their WST share price forecasts range from $250.00 to $350.00. On average, they predict the company's share price to reach $283.33 in the next year. This suggests a possible upside of 20.7% from the stock's current price.
View analysts price targets for WST
or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2022?

West Pharmaceutical Services' stock was trading at $469.01 at the start of the year. Since then, WST shares have decreased by 50.0% and is now trading at $234.66.
View the best growth stocks for 2022 here
.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a increase in short interest in November. As of November 15th, there was short interest totaling 993,800 shares, an increase of 18.1% from the October 31st total of 841,400 shares. Based on an average daily trading volume, of 680,900 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.4% of the shares of the company are sold short.
View West Pharmaceutical Services' Short Interest
.

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our WST earnings forecast
.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) announced its quarterly earnings results on Thursday, October, 27th. The medical instruments supplier reported $2.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.12 by $0.09. The medical instruments supplier earned $686.90 million during the quarter, compared to analyst estimates of $730.64 million. West Pharmaceutical Services had a net margin of 21.68% and a trailing twelve-month return on equity of 28.15%.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, October 27th. Stockholders of record on Wednesday, November 9th will be given a dividend of $0.19 per share on Wednesday, November 16th. This represents a $0.76 annualized dividend and a dividend yield of 0.32%. The ex-dividend date is Tuesday, November 8th. This is a boost from the stock's previous quarterly dividend of $0.18.
Read our dividend analysis for WST
.

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.76 per share and currently has a dividend yield of 0.34%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.17%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 10.16% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share (EPS) guidance of $8.15-$8.20 for the period, compared to the consensus estimate of $9.07. The company issued revenue guidance of $2.83 billion-$2.84 billion, compared to the consensus revenue estimate of $2.98 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.06%), BlackRock Inc. (10.93%), Price T Rowe Associates Inc. MD (5.23%), State Street Corp (4.50%), Bank of New York Mellon Corp (2.35%) and WCM Investment Management LLC (1.67%). Insiders that own company stock include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner, Quintin J Lai and Silji Abraham.
View institutional ownership trends
.

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $234.66.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services (NYSE:WST) has a market capitalization of $17.37 billion and generates $2.83 billion in revenue each year. The medical instruments supplier earns $661.80 million in net income (profit) each year or $8.29 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

The company employs 10,065 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The official website for the company is www.westpharma.com. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at quintin.lai@westpharma.com, or via fax at 800-345-9800.

This page (NYSE:WST) was last updated on 12/1/2022 by MarketBeat.com Staff